Sdz Msl-109
Cytomegalovirus Infections
National Center for Research Resources (NCRR)monoclonal_antibodyPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Cytomegalovirus Infections cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Foscarnet City of Hope Medical Center | Phase 4 | BB |
Valganciclovir The Methodist Hospital Research Institute | Phase 3 | BB |
Ganciclovir City of Hope Medical Center | Phase 3 | BB |
Cmvpp65-A*0201 Peptide Vaccine City of Hope Medical Center | Phase 2 | B |
Letermovir Fernanda P Silveira, MD, MS | Phase 2 | B |
View all 16 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →